DICE Therapeutics Inc (DICE) Actualités

Current Report Filing (8-k)

0001645569--12-30false00016455692023-06-072023-06-07   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549...

Current Report Filing (8-k)

false000164556900016455692023-05-112023-05-11   UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 8-K...

DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

First patient dosed in global Phase 2b clinical trial of lead oral IL-17 inhibitor, DC-806, in...

Quarterly Report (10-q)

Q10001645569--12-31false0001645569us-gaap:AgencySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001645569us-gaap:CommonSto...

Report of Proposed Sale of Securities (144)

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Report of Proposed Sale of Securities (144)

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF...

DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE) (DICE or...

Report of Proposed Sale of Securities (144)

Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...

Proxy Statement (definitive) (def 14a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...